G-Tech Medical
Private Company
Total funding raised: $17.9M
Overview
G-Tech Medical is a private medical device company pioneering a novel, non-invasive diagnostic platform for gastrointestinal motility disorders. Its flagship product, GutTracker®, is an FDA-cleared, wireless patch system that functions like an 'EKG for the gut,' collecting multi-day myoelectrical data from the entire GI tract to aid in the diagnosis of conditions like gastroparesis, IBS, and IBD. Founded in 2013 and based in San Jose, the company has conducted over 800 clinical tests, published multiple studies, and is now commercially available, positioning it to address a significant unmet need in gastroenterology. G-Tech operates as a 'Company in Residence' at Fogarty Innovation, leveraging this ecosystem for development and growth.
Technology Platform
Wireless dermal patch system (GutTracker®) that non-invasively detects and records myoelectrical signals from the stomach, small intestine, and colon over multiple days. The platform includes wearable patches, a smartphone app for Bluetooth data transmission, cloud-based data storage, and proprietary algorithms for signal analysis and organ-specific motility quantification.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
G-Tech faces competition from established but limited diagnostic methods like gastric emptying scans, manometry, and breath tests. Direct competitors offering non-invasive, multi-day GI monitoring are few, but larger players like Medtronic (via its GI diagnostics division) or new entrants could develop similar technologies. G-Tech's first-mover advantage with an FDA-cleared device is a key differentiator.